June 29, 2022
Using brain organoids, UC San Diego researchers discover mutational commonalities between muscular dystrophy type 1 and Rett syndrome, suggesting the potential of a similar treatment for both.
July 19, 2022
With a $45 million grant from the NIH, UC San Diego researchers and collaborators will launch a nationwide clinical trial to further investigate the therapeutic potential of benfotiamine, a synthetic version of thiamine (B1), as a treatment for Alzheimer’s disease.
September 6, 2022
Noted businessman and philanthropist T. Denny Sanford has committed $150 million in new funding to expand and, in some ways, quite literally launch stem cell research and regenerative medicine at University of California San Diego into new spaces and endeavors.
September 16, 2022
A UC San Diego study identifies neural mechanisms contributing to poorer cognition in aging adults; results may inspire new clinical interventions
September 26, 2022
New congressionally-directed funding awarding $5.6 million to Scripps Institution of Oceanography at the University of California San Diego will aim to improve characterization of the extent of the dumpsite, and support additional monitoring and research.
October 10, 2022
A new study by researchers at the University of California San Diego demonstrates a new neurotechnology geared toward answering a long-running question in neuroscience: How can scientists link the separate activity of many single neurons in the brain to the waves and oscillations of the local broade
November 10, 2022
An international symposium November 17-18, 2022 at UC San Diego will discuss current clinical trials using gene therapy, here and abroad.
November 3, 2022
Using human brain organoids, an international team of researchers has shown how the SARS-CoV-2 virus that causes COVID-19 infects cortical neurons and specifically destroys their synapses — the connections between brain cells that allow them to communicate with each other.
November 18, 2022
UC San Diego researchers used human brain organoids to study the effects of prenatal alcohol exposure on neural development, revealing significant harms in molecular detail.
December 12, 2022
Using models, researchers at UC San Diego School of Medicine, with colleagues elsewhere, describe using RNA-targeting CRISPR/Cas13d technology to develop a new therapeutic strategy that specifically eliminates toxic RNA that causes Huntington’s Disease.
